Anuj Malik

Prof. Anuj Malik

MM College of pharmacy, Maharishi Markandeshwar University (DU), Solan, Himāchal Pradesh, International
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
PMParth Malik
Parth Malik
RSRaj Singh
Raj Singh
MKMukesh Kumar
Mukesh Kumar
Anuj MalikAnuj Malik
Anuj Malik
TMTapan Mukherjee
Tapan Mukherjee
Prevalent as a major phenolic ingredient of soy and soy products, genistein is recognized as an eminent phytoestrogen owing to its interacting ability with estrogen receptors (ERs). The met-abolic conversion of plant-derived genistin to genistein by gut microbes and intestinal enzymes en-hances its absorption at intestinal pH of ~7.5-7.8. Genistein interferes in breast cancer (BC) devel-opment via pleiotropic actions on cell proliferation, survival, angiogenesis, and apoptosis. Though multiple investigations have demonstrated genistein intake-driven reduced BC risk, similar efficacy has not been replicated in clinical trials. Furthermore, multiple studies have structurally and func-tionally equated genistein extents with 17-β-estradiol (E2), the most available physiological estro-gen in females, culminating in aggravated BC growth. Of note, both genistein and E2 function via interacting with ERs (ERα and ERβ). However, although E2 shows almost equal affinity towards both ERα and ERβ, genistein shows more affinity towards ERβ than ERα. Our cautious literature survey revealed typical intake mode, ER expression pattern and the ratio of ERα and ERβ, transac-tivators/regulators of ERα and ERβ expression and activities, patient age, and menopausal status as decisive factors affecting genistein BC activities. Of further interest are the mechanisms by which genistein inhibits triple-negative breast cancers (TNBCs), which lack ERs, progesterone receptors (PRs), and human epidermal growth factor receptors (HER2). Herein, we attempt to understand the dosage-specific genistein actions in BC cells and patients with an insight into its better response via derivative development, nanocarrier-assisted, and combinatorial delivery with chemotherapeutic drugs.

2 May 2019 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
MKManish Kumar
Manish Kumar
PUPooja Upadhayay
Pooja Upadhayay
RSRavi Shankar
Ravi Shankar
MJMonika Joshi
Monika Joshi
SBShailendra Bahtt
Shailendra Bahtt
Anuj MalikAnuj Malik
Anuj Malik

1 February 2020 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
SBShailendra Bahtt
Shailendra Bahtt
DRDabashis Roy
Dabashis Roy
MKManish Kumar
Manish Kumar
RSRenu Saharan
Renu Saharan
Anuj MalikAnuj Malik
Anuj Malik
VSVipin Saini
Vipin Saini
Fast dispersible tablets (FDTs) get dispersed very fast due to which the discrimination of in vitro drug release and their evaluation is difficult. Hence in the present study a new in vitro discriminatory dissolution method was developed and validated for FDTs of domperidone of BCS class II. FDTs of domperidone were prepared by direct compression method. The dissolution studies were performed in an eight-station Electrolab TDT-082 dissolution testing apparatus, analyzed by ultraviolet spectrophotometer and evaluated in different dissolution mediums i.e. sodium lauryl sulphate (0.5%, 1.0% and 1.5%) with fresh distilled water, simulated intestinal fluid pH 6.8, simulated gastric fluid pH 1.2 without enzymes, phosphate buffer solution (pH 6.8) and 0.1 N hydrochloric acid at different agitation speeds. The developed method was validated in terms of specificity, accuracy, precision, linearity and robustness. Amongst the different mediums, 0.5% sodium lauryl sulfate (SLS) with distilled water was found to be optimum with higher rate of discriminatory power. The percentage recovery was found to be 96 to 100.12 % and the % relative standard deviation value for precision (intraday and interday) was found to be less than 1%. Also a dissolution profile of prepared FDTs were compared in distilled water containing 0.5% SLS using similarity (f2) and dissimilarity (f1) factor calculation which showed dissimilarity in release profile and confirms the discriminatory nature of developed method. The discriminatory dissolution method for FDTs was developed and validated. All the obtained results were satisfactory, accurate and in range. The current method could be beneficial for formulation development and for assessment of quality of FDTs.

30 November 2020 in Nanoscience & Nanotechnology-Asia
Verified
Journal Article
Closed access
PDF file
SRSarvjeet Singh Rana
Sarvjeet Singh Rana
SBShailendra Bahtt
Shailendra Bahtt
MKManish Kumar
Manish Kumar
Anuj MalikAnuj Malik
Anuj Malik
JSJai Bharti Sharma
Jai Bharti Sharma
VSVipin Saini
Vipin Saini
Introduction: Solid Lipid nanoparticles (SLN) are comprising of a solid lipid core with a mean diameter between 50 and 1000 nm. SLN is an advanced carrier system to traditional colloidal carriers such as emulsion, liposomes, and polymeric microparticles. Objective: The objective of this study was to formulate SLN of Itraconazole (ITZ) for intranasal administration. Methods: ITZ-loaded SLN were prepared by high pressure homogenization technique using the Central Composite Design (CCD). The concentration of surfactant (X1) and drug to lipid ratio (X2) was considered as independent variables, whereas particle size (Y1) and percentage entrapment efficiency (Y2) were considered as a response. The compatibility of ingredients with the drug was tested using differential scanning calorimetry. SLN were characterized for their particle size, entrapment efficiency, transmission electron microscopy, in vitro drug release, and ex vivo study. Results: The solid lipid nanoparticles were successfully prepared using high pressure homogenization technique and glyceryl monostearate was used as solid lipid. The lipid ratio significantly increases the particle size as well as entrapment efficiency. The particle size and (%) entrapment efficiency of optimized formulation were found to be 29 nm and 78.9%, respectively. The differential scanning calorimetry confirmed that the drug existed in amorphous form. Nasal histopathology study on sheep mucosa revealed that the developed SLN was non-toxic and safe to use for intranasal administration. The results of ex vivo study showed that the Higuchi pattern of drug release was followed. The in vitro release studies showed the significant difference in drug release from ITZ-loaded SLN compared to plain ITZ-solution. Conclusion: ITZ-loaded SLN were successfully prepared and validated. The best batch was selected based on the desired particle size, and EE which is an important characteristic for SLN formulations. The developed formulations were nontoxic as determined by histo-pathological studies.

1 January 2014
Verified
Conference Paper
Closed access
PDF file
Anuj MalikAnuj Malik
Anuj Malik
WWWayne Wauford
Wayne Wauford
ZPZhong Pan
Zhong Pan
NGNitin K Goel
Nitin K Goel
SHSteven Hand
Steven Hand
MMMatthew Mitchell
Matthew Mitchell
This paper proposes CDC ROADM architecture compatible with emerging DWDM super-channel technology. A real world network model is used to quantify that this architecture requires fewer network components leading to less capital and operational costs.

30 August 2022 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
UHUditi Handa
Uditi Handa
Anuj MalikAnuj Malik
Anuj Malik
GKGuarve Kumar
Guarve Kumar
Superfluity drug delivery system (SFDDS) is an auspicious conception to obtain adequate oral bioavailability of poorly soluble drugs especially those drugs which are belongs to Biopharmaceutical Classification System II. The drug is in the form of high energy or otherwise swiftly dissolving form such that generated the drug in intraluminal concentrations above the saturation solubility which is liable for desired pharmacological response to the systemic circulation due to superfluity mechanism. The mechanism is based upon spring-parachute and hang-glider effect which involves the inhibition of nucleation with the help of precipitation inhibitors which will act as parachute and glider effect in superfluity formulations and the spring and hang will act as technology used to formulated the dosage form such as amorphous solid dispersion, co-crystals, supersaturated self-emulsifying drug-delivery system correlating to want the biological response is inadequate in the aqueous solubility of drug encountered with formulation development of new drug and existing drug as well as for the new formulation development of existing drug. The methods related to solubilization process are not necessarily improving the absorption in GIT i.e., the free fraction of drug molecules in the inter-micellar phase is limited at the time of dissolution process of the intestinal barrier. This review articles belongs to mechanism of superfluity strategy which overcomes many of the obstacles and limitations of solubilization methods especially very poorly water-soluble drug.